Choose Your Country or Region

Povidone iodine

Name: Povidone iodine
Brand: Selleck Chemicals
SKU: S4678
Rating: 5 (1 reviews)

Synonyms: Betadine, PVP iodine, PVP-I, Isodine

Catalog No.S4678 Purity: 99%

Povidone iodine (Betadine, PVP iodine, PVP-I, Isodine) is a stable chemical complex of polyvinylpyrrolidone (povidone, PVP) and elemental iodine. Povidone iodine displays excellent antibacterial activity against MRSA and MSSA strains with MICs of 31.25 mg/L and 7.82 mg/L, respectively. Povidone iodine is used as a topical antiseptic in surgery and for skin and mucous membrane infections, as well as as an aerosol.

Povidone iodine Chemical Structure

CAS: 25655-41-8

Purity & Quality Control

Batch: S467801 DMSO] 28 mg/mL] false] Water] 28 mg/mL] false] Ethanol] 28 mg/mL] false Purity: 99%

Povidone iodine Related Products

Related Products	PEG300 CMC-Na SBE-β-CD Tween 80 (2-Hydroxypropyl)-β-cyclodextrin (HP-β-CD) PEG400 Pluronic F-68	Click to Expand
Related Compound Libraries	Anti-infection Compound Library Antibiotics compound Library Antiviral Compound Library Anti-parasitic Compound Library Gut Microbial Metabolite Library	Click to Expand

Choose Selective Hydrotropic Agents Inhibitors

Biological Activity

Description

In vitro
In vitro	Exposure to PVP-I, of which concentrations are even lower than those used clinically, causes toxicity in epithelial cells^[2].
Cell Research	Cell lines	HeLa cells
	Concentrations	0.01-1000 μM
	Incubation Time	1 or 2 days
	Method	One day after seeding, wells are exposed to PVP-I (0.01 to 1000 μM), which has been diluted with DMEM containing 10% FBS. Plates are further cultured for 1 or 2 days at 37℃ in a 5% CO2 incubator. The cell incubation time of 1 or 2 days is determined based on data regarding the onset time of iododerma and nephropathy pathogenesis.

In Vivo
In vivo	Povidone-iodine is a broad spectrum antiseptic for topical application in the treatment and prevention of infection in wounds, using the antiseptic properties of iodine. A study investigating its use in defective tissue in neural structures reveals that Myelin changes are absent or minimal in all cases of the control group but are present as markedly increased myelin degeneration in nearly all cases in the PVP-I group. Axonal degeneration and hypoxic neuronal damage are absent in the control group, whereas they are marked in half of the PVP-I group. No statistically significant differences are established in Schwann cell proliferation, venous congestion, and lymphocytic proliferation between the two groups^[1].

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2024-01-11)
NCT05745467	Withdrawn	SARS-CoV-2 Acute Respiratory Disease	University of Iowa\|3M	July 3 2024	Phase 4
NCT05696132	Not yet recruiting	MRSA	Nantes University Hospital	February 2023	Phase 2
NCT05704959	Active not recruiting	HEALTHY INDIVIDUALS	Hasan Kalyoncu University	March 15 2022	Not Applicable
NCT05077592	Unknown status	Surgical Site Infection\|Surgical Wound Infection	Ain Shams University	September 18 2021	Phase 4
NCT04658355	Unknown status	Vaginal Flora Imbalance	University of Arizona	December 15 2020	Not Applicable

References

Chemical Information & Solubility

Molecular Weight		Formula	(C₆H₉NO)x.xI₂
CAS No.	25655-41-8	SDF	Download Povidone iodine SDF
Smiles	C=CN1CCCC1=O.II
Storage (From the date of receipt)	3 years-20°Cpowder	Storage of Stock Solutions Aliquot the stock solutions to avoid repeated freeze-thaw cycles	1 year-80°Cin solvent
Storage (From the date of receipt)	3 years-20°Cpowder		1 month-20°Cin solvent

In vitro
Batch:

DMSO : 28 mg/mL ( ； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 28 mg/mL

Ethanol : 28 mg/mL

Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.

In vivo Formulation Calculator

Preparing Stock Solutions

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):